Corbus Pharmaceuticals Holdings, Inc.

NASDAQ:CRBP

Biotechnology

Healthcare
$2.44 +1.73%

+$0.14 today

Market cap
$50.18M
Beta
2.59
P/E (TTM)
-1.3
EPS (TTM)
-$6.35
52W Low $6.72High $20.56

Volume 0.66M

Average 0.42M

Balance Sheet

Inspect the capital base behind the business.

Assets

$168.19M

FY 2025 · Annual

+7.9% YoY

Liabilities

$20.69M

FY 2025 · Annual

+53.8% YoY

Equity

$147.50M

FY 2025 · Annual

+3.6% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents25.01M17M13.72M17.2M28.49M
Short-term Investments72.64M42.19M7.18M131.86M134.78M
Net Receivables00001.5M
Inventory00000
Other Current Assets192.48K192.48K192K3.91M1.52M
Total Current Assets100.2M60.18M23.55M152.98M166.95M
Property, Plant & Equipment (Net)7M5.5M4.04M2.52M1.24M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets523.81K632.77K690K385K0
Total Non-current Assets7.53M6.13M4.73M2.9M1.24M
Total Assets107.73M66.31M28.27M155.88M168.2M
Account Payables1.78M2.17M3.18M4.79M2.22M
Short-term Debt3.86M3.15M16.21M00
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities133.71K36.87K39K2.28M2.86M
Total Current Liabilities17.01M12.64M31.89M11.82M20.69M
Long-term Debt15.64M15.98M000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities22.21K22.21K44K00
Total Non-current Liabilities21.61M20.68M3.28M1.63M0
Total Liabilities38.62M33.32M35.18M13.45M20.69M
Common Stock12.52K41701K2K
Retained Earnings(349.73M)(392.08M)(436.68M)(476.89M)(555.43M)
Accumulated OCI(62.45K)(126.09K)(1K)35K(53K)
Other Stockholders Equity00(0)00
Minority Interest00000
Total Equity69.11M32.99M(6.91M)142.43M147.5M
Total Debt26.59M25.09M20.89M3.24M1.63M
Net Debt1.58M8.09M7.16M(13.96M)(26.86M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$26.0M
Short-term Investments$112.6M
Other Current$5.0M
Total Current Assets$143.6M
PP&E (Net)$914.0K
Other Non-current-$1
Total Non-current Assets$914.0K
Total Assets$144.5M

Analysis

Selected assets total $144.5M for Latest. The largest visible component is Short-term Investments at $112.6M, about 77.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 13, 2026
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
4Statement of changes in beneficial ownershipNov 2, 2026
SC 13G/ASC 13G/A filingNov 2, 2026

How much cash does CRBP have?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported $28.49M in cash and equivalents in fiscal 2025.

How much debt does CRBP carry?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported $1.63M of total debt, with net debt of -$26.86M.